Name | Number of supported studies | Average coverage | |
---|---|---|---|
platelet | 10 studies | 68% ± 20% | |
megakaryocyte | 6 studies | 80% ± 20% |
Insufficient scRNA-seq data for expression of GP9 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
spleen | 100% | 314.55 | 241 / 241 | 0% | 0 | 0 / 0 |
lung | 90% | 124.04 | 519 / 578 | 3% | 0.04 | 29 / 1155 |
peripheral blood | 81% | 681.92 | 754 / 929 | 0% | 0 | 0 / 0 |
intestine | 10% | 2.65 | 100 / 966 | 7% | 0.22 | 38 / 527 |
brain | 1% | 0.15 | 20 / 2642 | 10% | 0.21 | 68 / 705 |
thymus | 8% | 1.84 | 51 / 653 | 1% | 0.02 | 8 / 605 |
kidney | 2% | 0.76 | 2 / 89 | 7% | 0.12 | 59 / 901 |
liver | 8% | 1.92 | 18 / 226 | 0% | 0.01 | 2 / 406 |
adipose | 6% | 1.38 | 67 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 5% | 1.34 | 69 / 1335 | 0% | 0 | 0 / 0 |
breast | 5% | 0.97 | 22 / 459 | 0% | 0.01 | 4 / 1118 |
adrenal gland | 0% | 0 | 0 / 258 | 5% | 0.20 | 11 / 230 |
stomach | 1% | 0.14 | 3 / 359 | 3% | 0.06 | 9 / 286 |
heart | 3% | 1.00 | 28 / 861 | 0% | 0 | 0 / 0 |
esophagus | 1% | 0.19 | 9 / 1445 | 2% | 0.05 | 4 / 183 |
pancreas | 0% | 0 | 0 / 328 | 2% | 0.09 | 4 / 178 |
uterus | 1% | 0.15 | 1 / 170 | 2% | 0.05 | 7 / 459 |
prostate | 1% | 0.23 | 3 / 245 | 1% | 0.01 | 4 / 502 |
bladder | 0% | 0 | 0 / 21 | 2% | 0.03 | 10 / 504 |
ovary | 1% | 0.18 | 2 / 180 | 0% | 0 | 0 / 430 |
skin | 0% | 0.03 | 3 / 1809 | 1% | 0.01 | 3 / 472 |
muscle | 1% | 0.12 | 5 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007597 | Biological process | blood coagulation, intrinsic pathway |
GO_0010572 | Biological process | positive regulation of platelet activation |
GO_0007155 | Biological process | cell adhesion |
GO_0007596 | Biological process | blood coagulation |
GO_0051209 | Biological process | release of sequestered calcium ion into cytosol |
GO_0035855 | Biological process | megakaryocyte development |
GO_1990779 | Cellular component | glycoprotein Ib-IX-V complex |
GO_0005886 | Cellular component | plasma membrane |
GO_0005515 | Molecular function | protein binding |
Gene name | GP9 |
Protein name | Platelet glycoprotein IX (GP-IX) (GPIX) (Glycoprotein 9) (CD antigen CD42a) Truncated glycoprotein IX (Platelet) |
Synonyms | |
Description | FUNCTION: The GPIb-V-IX complex functions as the vWF receptor and mediates vWF-dependent platelet adhesion to blood vessels. The adhesion of platelets to injured vascular surfaces in the arterial circulation is a critical initiating event in hemostasis. GP-IX may provide for membrane insertion and orientation of GP-Ib. |
Accessions | ENST00000307395.5 P14770 D1MER8 |